News & Updates
Filter by Specialty:
Probiotics, prebiotics, synbiotics boost metabolism in NAFLD
Patients with nonalcoholic fatty liver disease (NAFLD) who take probiotics, prebiotics, or synbiotics (PPS) may have better energy metabolism, according to a recent study.
Probiotics, prebiotics, synbiotics boost metabolism in NAFLD
19 Aug 2022
Psychotherapy for alcohol use disorder extends benefit to alcohol-related liver disease
Undergoing psychotherapy for alcohol use disorder (AUD) helps prevent the incidence and progression of alcohol-associated liver disease (ALD), according to a study.
Psychotherapy for alcohol use disorder extends benefit to alcohol-related liver disease
18 Aug 2022
HCV reinfection highest among people with ongoing injecting drug use
Reinfection with hepatitis C virus (HCV) is low among people receiving opioid agonist therapy (OAT) but appears to be at its peak during the first 24 weeks following treatment completion and among those with ongoing injecting drug use and needle‒syringe sharing, a study has found.
HCV reinfection highest among people with ongoing injecting drug use
14 Aug 2022
RATIONALE-208 subanalyses boost tislelizumab potential for HCC
The monoclonal antibody tislelizumab continued to show promise as a treatment alternative in certain subgroups of patients with previously treated advanced hepatocellular carcinoma (HCC), according to subgroup analyses of the phase II, single-arm RATIONALE-208 study.